Dolby Laboratories, Inc.DLBNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +13.13% | +1.38% | +9.25% | +0.73% | -2.88% |
| Gross Profit Growth | +11.54% | +2.45% | +7.26% | -1.22% | -4.02% |
| EBITDA Growth | +9.29% | +1.51% | +0.17% | -28.22% | -7.83% |
| Operating Income Growth | +17.68% | +5.17% | +16.59% | -34.14% | -26.95% |
| Net Income Growth | +1.26% | -6.17% | +19.84% | -15.77% | -21.37% |
| EPS Growth | +1.43% | -6.86% | +20.00% | -14.75% | -21.13% |
| EPS Diluted Growth | +1.45% | -6.93% | +20.00% | -16.39% | -21.43% |
| Weighted Average Shares Growth | +0.25% | +0.64% | +0.22% | +0.25% | -0.16% |
| Weighted Average Shares Diluted Growth | -0.30% | +0.63% | -0.06% | +0.26% | -0.65% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1169.82% | -3.59% | +218.34% | +5.73% | -48.68% |
| Free Cash Flow Growth | +4229.00% | -2.60% | +348.78% | -7.17% | -50.58% |
| Receivables Growth | +9.67% | +3.65% | +5.32% | +0.00% | +1.99% |
| Inventory Growth | -15.27% | -3.36% | -6.63% | +0.00% | -1.79% |
| Asset Growth | +7.60% | +6.05% | +7.48% | +0.00% | +1.06% |
| Book Value per Share Growth | +6.64% | +5.64% | +6.83% | +0.00% | +3.58% |
| Debt Growth | -5.92% | -22.12% | -18.84% | +0.00% | -8.56% |
| R&D Expense Growth | -0.59% | -1.26% | +0.73% | -1.71% | +3.66% |
| SG&A Expenses Growth | +14.10% | +2.08% | +7.95% | +4.54% | -1.64% |